» Articles » PMID: 23880644

Proteomic Techniques for Characterisation of Mesenchymal Stem Cell Secretome

Overview
Journal Biochimie
Specialty Biochemistry
Date 2013 Jul 25
PMID 23880644
Citations 128
Authors
Affiliations
Soon will be listed here.
Abstract

Mesenchymal stem cells (MSCs) are multipotent cells with a substantial potential in human regenerative medicine due to their ability to migrate to sites of injury, capability to suppress immune response and accessibility in large amount from patient's own bone marrow or fat tissue. It has been increasingly observed that the transplanted MSCs did not necessarily engraft and differentiate at the site of injury but might exert their therapeutic effects through secreted trophic signals. The MSCs secrete a variety of autocrine/paracrine factors, called secretome, that support regenerative processes in the damaged tissue, induce angiogenesis, protect cells from apoptotic cell death and modulate immune system. The cell culture medium conditioned by MSCs or osteogenic, chondrogenic as well as adipogenic precursors derived from MSCs has become a subject of intensive proteomic profiling in the search for and identification of released factors and microvesicles that might be applicable in regenerative medicine. Jointly with the methods for MSC isolation, expansion and differentiation, proteomic analysis of MSC secretome was enabled recently mainly due to the extensive development in protein separation techniques, mass spectrometry, immunological methods and bioinformatics. This review describes proteomic techniques currently applied or prospectively applicable in MSC secretomics, with a particular focus on preparation of the secretome sample, protein/peptide separation, mass spectrometry and protein quantification techniques, analysis of posttranslational modifications, immunological techniques, isolation and characterisation of secreted vesicles and exosomes, analysis of cytokine-encoding mRNAs and bioinformatics.

Citing Articles

Conditioned Medium Derived From Human Dental Follicle Mesenchymal Stem Cells Alleviates Macrophage Proinflammatory Responses Through MAPK-ERK-EGR1 Axis.

Zhang C, Lv P, Liang Q, Zhou J, Wu B, Xu W Stem Cells Int. 2024; 2024:5514771.

PMID: 39650749 PMC: 11623994. DOI: 10.1155/sci/5514771.


Combination Therapy with Secretome of Reovirus-Infected Mesenchymal Stem Cells and Metformin Improves Anticancer Effects of Irinotecan on Colorectal Cancer Cells in vitro.

Elhamipour M, Soleimanjahi H, Abdoli A, Sharifi N, Karimi H, Soleyman Jahi S Intervirology. 2024; 68(1):1-16.

PMID: 39561737 PMC: 11658782. DOI: 10.1159/000542356.


Enhancing Bone Formation Through bFGF-Loaded Mesenchymal Stromal Cell Spheroids During Fracture Healing in Mice.

Takeda K, Saito H, Shoji S, Sekiguchi H, Matsumoto M, Ujihira M Bioengineering (Basel). 2024; 11(10).

PMID: 39451415 PMC: 11504918. DOI: 10.3390/bioengineering11101041.


Amelioration of behavioral and histological impairments in somatosensory cortex injury rats by limbal mesenchymal stem cell transplantation.

Derakhshani A, Taheri F, Geraminia N, Mohammadipoor-Ghasemabad L, Sabzalizadeh M, Vafee F Transl Neurosci. 2024; 15(1):20220346.

PMID: 39156044 PMC: 11330157. DOI: 10.1515/tnsci-2022-0346.


Role of Mesenchymal Stem/Stromal Cells in Head and Neck Cancer-Regulatory Mechanisms of Tumorigenic and Immune Activity, Chemotherapy Resistance, and Therapeutic Benefits of Stromal Cell-Based Pharmacological Strategies.

Starska-Kowarska K Cells. 2024; 13(15.

PMID: 39120301 PMC: 11311692. DOI: 10.3390/cells13151270.